Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.

MLA

Perkovic, Vlado, et al. “Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.” The New England Journal of Medicine, Oct. 2024. EBSCOhost, https://doi.org/10.1056/NEJMoa2410316.

APA

Perkovic, V., Barratt, J., Rovin, B., Kashihara, N., Maes, B., Zhang, H., Trimarchi, H., Kollins, D., Papachristofi, O., Jacinto-Sanders, S., Merkel, T., Guerard, N., Renfurm, R., Hach, T., & Rizk, D. V. (2024). Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2410316

Chicago

Perkovic, Vlado, Jonathan Barratt, Brad Rovin, Naoki Kashihara, Bart Maes, Hong Zhang, Hernán Trimarchi, et al. 2024. “Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.” The New England Journal of Medicine, October. doi:10.1056/NEJMoa2410316.